Literature DB >> 14597438

One hundred laparoscopic adrenalectomies: a single surgeon's experience.

Herbert J Zeh1, Robert Udelsman.   

Abstract

BACKGROUND: Since the first laparoscopic adrenalectomy was performed in 1992, it has quickly gained acceptance as the standard of care for the treatment of benign adrenal neoplasms. We report a single surgeon's experience with 100 consecutive laparoscopic adrenalectomies.
METHODS: The records of all patients having adrenalectomy at the Johns Hopkins Hospital from 1993 until 2000 were reviewed. We examined the length of stay, time to diet resumption, perioperative morbidity, operative cost, and total cost of 100 consecutive laparoscopic adrenalectomies. These data are compared with those of 20 patients within our institution having open adrenalectomy and with 428 patients statewide having all forms of adrenalectomy during the same time period.
RESULTS: A total of 93 patients had unilateral laparoscopic adrenalectomy and 7 had bilateral procedures. The mean age was 49 years (11 to 70). Indications were aldosteronoma (n = 40), pheochromocytoma (n = 22), glucocorticoid-producing adenoma (n = 14), nonfunctioning adenoma (n = 12) Cushing's disease (n = 5), and others (n = 7). The median length of stay for this series was 1.0 day. Average length of stay and time to resumption of diet were 1.8 and 1.0 days, respectively. Patients having open procedures during this same time period had an average length of stay of 6.5 days.
CONCLUSIONS: Laparoscopic adrenalectomy provides clear advantages over open adrenalectomy. Patients having laparoscopic adrenalectomy have decreased length of stay, shorter time to resumption of diet, and lower total hospital charges when compared with those having open adrenalectomy.

Entities:  

Mesh:

Year:  2003        PMID: 14597438     DOI: 10.1245/aso.2003.06.001

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  17 in total

Review 1.  Diagnosis and surgical management for primary hyperaldosteronism.

Authors:  Ravi Munver; Jennifer Yates
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

2.  Laparoscopic adrenalectomy in pheochromocytomas.

Authors:  M Guerrieri; M Baldarelli; M Scarpelli; S Santini; G Lezoche; E Lezoche
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

Review 3.  Minimal access adrenal surgery.

Authors:  L M Brunt
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

4.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

5.  Previously unreported high-grade complications of adrenalectomy.

Authors:  Deron J Tessier; Rafael Iglesias; William C Chapman; Kent Kercher; Brent D Matthews; D Lee Gorden; L Michael Brunt
Journal:  Surg Endosc       Date:  2008-04-29       Impact factor: 4.584

Review 6.  Adrenocortical carcinoma: which surgical approach?

Authors:  Bruno Carnaille
Journal:  Langenbecks Arch Surg       Date:  2011-09-27       Impact factor: 3.445

Review 7.  Current and emerging therapies for advanced adrenocortical carcinoma.

Authors:  Lyndal J Tacon; Ruth S Prichard; Patsy S H Soon; Bruce G Robinson; Roderick J Clifton-Bligh; Stan B Sidhu
Journal:  Oncologist       Date:  2011-01-06

8.  Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience.

Authors:  Sarah K Thompson; Amanda V Hayman; William H Ludlam; Clifford W Deveney; D Lynn Loriaux; Brett C Sheppard
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

9.  Laparoscopic adrenalectomy: lessons learned from an initial series of 100 patients.

Authors:  A Gil-Cárdenas; C Cordón; R Gamino; J A Rull; F Gómez-Pérez; J P Pantoja; M F Herrera
Journal:  Surg Endosc       Date:  2007-08-19       Impact factor: 4.584

Review 10.  Laparoscopic distal pancreatectomy for adenocarcinoma: safe and reasonable?

Authors:  Lauren M Postlewait; David A Kooby
Journal:  J Gastrointest Oncol       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.